Main menu

Cell and gene therapy

Descripción general
Cell and gene therapy research document repository
71 resultados
Getting started guide: biopharmaGetting started guide

Getting started guide: biopharma

This guide introduces Oxford Nanopore sequencing solutions for biopharma that can be applied from biomarker discovery through to final product quality control (QC) testing.

Nanopore sequencing enables scalable, end-to-end quality control and capsid library profiling of recombinant AAV vectors | LC26Event video

Nanopore sequencing enables scalable, end-to-end quality control and capsid library profiling of recombinant AAV vectors | LC26

Recombinant adeno-associated viruses (rAAVs) are among the most widely used vectors for gene therapy, requiring stringent quality control to ensure vector integrity, safety, and therapeutic performance. Oxford Nanopore Technologies ...

Advanced analytics for biopharma using nanopore sequencing | LC26Event video

Advanced analytics for biopharma using nanopore sequencing | LC26

Biologics encompass a diverse range of customizable agents (mRNAs, cell lines, and viral products) derived from living organisms. Both their evolution as well as their ever-expanding number of applications ...

Workflow overview: NO-MISSWorkflow overview

Workflow overview: NO-MISS

This end-to-end workflow provides a rapid solution for whole-genome Oxford Nanopore sequencing of bacterial and fungal isolates.

De-risking RNA therapeutics with high-resolution sequencingWebinar

De-risking RNA therapeutics with high-resolution sequencing

Watch on demand to learn how integrating sequencing-driven insights across development and manufacturing can reduce risk and strengthen confidence as RNA programs advance toward the clinic.

Workflow overview: amplicon sequencingWorkflow overview

Workflow overview: amplicon sequencing

This end-to-end workflow introduces how to validate full-length amplicons with Oxford Nanopore sequencing.

Workflow overview: pharmacogenomics with adaptive samplingWorkflow overview

Workflow overview: pharmacogenomics with adaptive sampling

This end-to-end workflow introduces how to enrich a comprehensive panel of PGx targets with real-time targeted Oxford Nanopore sequencing.

Workflow overview: AAV sequencingWorkflow overview

Workflow overview: AAV sequencing

This end-to-end workflow provides a simple method to characterise full-length, native AAV vectors for QC measures.

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Modern slavery policy Accessibility

About Oxford Nanopore

Contact us News Media resources & contacts Investor centre Careers BSI 27001 accreditationBSI 90001 accreditation

© 2008 - 2026 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, AmPORE-TB, EPI2ME, GridION, MinION, MinKNOW, PromethION, P2 Solo, and P2 are registered trademarks or the subject of trademark applications of Oxford Nanopore Technologies plc in various countries. Information contained herein may be protected by copyright, patents or patents pending of Oxford Nanopore Technologies plc. All other brands and names contained are the property of their respective owners. Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in‐vitro diagnostic devices in some jurisdictions, please check individual product labelling.

Spanish flag